David Chang, Allogene (Jeff Rumans)

Al­lo­gene spot­lights their off-the-shelf CAR-T con­tender ‘501 with a snap­shot on CRs and no GVHD

Al­lo­gene ex­ecs are out to rev­o­lu­tion­ize a field they played a ma­jor role in pi­o­neer­ing. And they will ar­rive — vir­tu­al­ly — at AS­CO with some …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.